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pen accessAbstract Background: We evaluated the safety and efﬁcacy of thoracic paravertebral block as a
method of pain relief after thoracotomy in comparison with systemic opioids.
Study design: Randomized controlled trial.
Methods: We scheduled 40 patients divided into two groups to receive either 20 ml bupivacaine
(0.5%) incremental injections for intra and postoperative analgesia via a catheter inserted in the
thoracic paravertebral space. The other 20 patients received systemic morphine for postoperative
analgesia. We recorded postoperative Visual Analog Scale pain score, total morphine consumption,
time to ﬁrst analgesic request, changes in pulmonary functions and side effects.
Results: Visual analogue scale (VAS) at rest was lower in the paravertebral group at all measurement
points except at 16, 20 and 24 h postoperatively. Pain on coughing showed signiﬁcant difference (P
value < 0.05) at 8 and 16 h but not at 24 h. Post-operative consumption of morphine was 36 (22–
42) mg in the control group versus 9 (2–22) mg in the paravertebral block group (PVB) (P
value = 0.003). Total bupivacaine dose used in the PVB group in the ﬁrst 24 h was 300–420 mg. For
time to ﬁrst analgesic request it was signiﬁcantly longer in the morphine group than the paravertebral
block group. VAS at ﬁrst analgesic request was not statistically different between the two groups.
There was no signiﬁcant difference between the two groups as regards to peak expiratory ﬂow rate
(PEFR) preoperatively, after 12 h or 24 h.5262075.
(S.M. Asida).
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56 S.M. Asida et al.There was a signiﬁcant reduction in the incidence of side effects in the TPVB group compared to mor-
phine group concerning vomiting and pruritus.no local anesthetic toxicity was reported.
Conclusion: Weconclude that thoracic PVBprovides effective post thoracotomy analgesia supported
by lower VAS pain scores at rest and on coughing compared to intravenousmorphine with signiﬁcant
less incidence of side effects.
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Thoracotomy produces many damaging surgical insults
causing severe pain. This pain arises from chest wall trauma,
including surgically fractured ribs, damaged peripheral nerves,
and CNS hyperexitability. Part of this pain is due to continu-
ous movement of the chest wall with respiration and if we
consider clearing of secretions from the airway passages an
additional problem is added. Patients may be elderly, malnour-
ished, or have frequently cardiac and respiratory diseases.
We searched for many methods to control post-thoracot-
omy pain. Considering the origin of pain we found that regio-
nal modes of analgesia are more logic, this is because pain
which occurs with intercostal nerve damage resulting from
chest wall trauma in addition to CNS hyperexcitability are
poorly sensitive to opioids for effective analgesia it seems
better to start regional analgesic regimen in the pre-operative
period and continue throughout the operation and for sufﬁ-
cient time after operation until wound healing is established
[1].
Thoracic paravertebral block (TPVB) is a regional tech-
nique to block spinal nerves at the site where they emerge from
the intervertebral foramina by injecting local anesthetic. It pro-
duces ipsilateral somatic and sympathetic nerve blockade in
the thoracic dermatomes above and below the site of injection.
Bilateral use of TPVB has been also described [2].
The aim of this study was to compare the safety and efﬁ-
cacy of thoracic paravertebral block as a method of pain relief
following thoracotomy as compared to systemic morphia.
2. Patients and methods
The Ethical Committee of El-Minya Faculty of Medicine
approved this prospective randomized study which was done
in El-Minya university hospital in the period from April
2008 to April 2010. Written informed consents were obtained
from 40 patients scheduled for lung surgery via a posterolat-
eral midthoracic thoracotomy incision without costectomy.
The aim of this study was to compare the safety and efﬁ-
cacy of the thoracic para-vertebral block as a method of pain
relief following thoracotomy as compared to intravenous
morphine.
Patients who were under 18 or over 70 years of age, weighed
<50 kg or>100 kg, had an ASA physical status more than III,
had an active pulmonary infectious process, a neurological dis-
order, were receiving opioid therapy for chronic pain, had
abnormal coagulation tests, also patients with spine deformities
or those who could not express pain intensity by visual analogue
scale (VAS), these groups were excluded from the study.
Patients were assigned by pre-randomized, sealed envelopes
to receive one of two different analgesic techniques: Group 1,
general anesthesia (GA) followed by IV morphine (n= 20);and Group II, general anesthesia (n= 20) followed by
thoracic paravertebral block.
2.1. Pre-anesthetic procedures
The pre-anesthesia procedure was the same in all patients: the
patients were not pre-medicated before arrival in the operating
room. After arrival, they were pre-hydrated (Ringer’s lactate
8 mL/kg/h), monitored (electrocardiography, noninvasive
blood pressure, and oxygen saturation in blood). Before the
operation, postoperative pain relief technique during the ﬁrst
48 h and how to use the visual analogue scale (VAS) for
expression of pain was explained to all patients.
Pre and postoperative respiratory functions were tested.
Peak expiratory ﬂow rate (PEFR) was measured using an
AsmaPLAN+ peak ﬂow meter (Vitalograph, Milton Keynes,
UK). In a sitting position after maximal inspiration, the
patient was requested to exhale completely as fast as possible
into the peak ﬂow meter. The mean value of three measure-
ments was recorded.
2.2. Anesthesia
Patients randomized to receive GA (group 1) received mor-
phine (0.1 mg/kg) as a pre-emptive analgesia before induction
of anesthesia while group II were given this dose of morphine
after conducting the paravertebral block. Anesthesia in the two
groups was induced with propofol 1.5–2 mg/kg IV and atracu-
rium 0.5 mg/kg IV to facilitate the intubation of the trachea.
Anesthesia was maintained with isoﬂurane in oxygen and
incremental doses of atracurium (0.1 mg/kg). The isoﬂurane
concentration was adjusted with the intention of keeping heart
rate and blood pressure within ±25% of pre-induction values.
Also, ephedrine 10 mg was given IV as needed for the same
purpose. At the end of the operation, residual neuromuscular
block was reversed with neostigmine (0.05 mg/kg) and atro-
pine (0.01 mg/kg) before extubation. Electrocardiography,
noninvasive blood pressure, SpO2, central venous pressure
and end tidal CO2 were monitored throughout the operative
period.
Demographic variables, including age, gender, height, ASA
physical status and weight, were recorded, in addition to pre-
operative PEFR. Intra-operatively hemodynamic data were re-
corded; these data included mean arterial blood pressure, heart
rate, and oxygen saturation in blood.
Isoﬂurane administration was stopped at the beginning of
parietal closure. At the end of the procedure, the patients were
awakened and their tracheas extubated if they met standard
extubation criteria (regular breathing, end-tidal carbon dioxide
<45 mm Hg and SpO2 more than 95%). The patients were
transferred to the recovery room for close monitoring over
the next 24 h (heart rate, blood pressure, oxyhemoglobin
Table 1 Patients, characteristics in the two groups. Values are
shown as mean ± SD and range.
Variables Group I (n= 20) Group II (n= 20)
Age (year) 55 ± 11 52 ± 8
Weight (kg) 79 ± 11 77 ± 11
Height (cm) 166 ± 5 164 ± 5
ASA I/II/III (n) 8/10/2 5/13/2
Gender (F/M) 7/13 8/12
Pre-operative respiratory
functions (L/min)
370 (280–490) 330 (260–450)
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tients received oxygen via a face mask to maintain SpO2 more
than 90% throughout the study period.
2.3. Post-anesthesia
When sufﬁciently awake for pain assessment, patients were
asked to score pain on the VAS. A score more than 30 mm
indicated pain requiring an analgesic administration in the
form of IV morphine (0.05 mg/kg until the VAS pain score
at rest was <30 mm) for patients in the control group. While
patients in the PVB group received ﬁrstly bupivacaine in the
paravertebral catheter (20 ml bupivacaine 0.5% in 5 ml incre-
ments) then patients were asked to score pain at rest and on
coughing on VAS scores, if VAS scores still >30 mm mor-
phine was given as patients in the control group. Patients re-
ceived no sedatives or opioids other than IV morphine. IV
morphine consumption was recorded in all patients. Also total
bupivacaine dose (mg) was recorded in PVB group.
Pain at rest was scored on the VAS every 2 h from T2 (time
2 h postoperative) to T12 h and every 4 h for T12–T24 h. Pain
on coughing was scored every 8 h on the VAS.
Side effects such as pruritus, nausea and vomiting were re-
corded over the 24 h study period.
2.4. Technique of thoracic paravertebral block
The patient in group 2 was placed in the lateral decubitus or
sitting position. Complete aseptic condition was achieved by
painting the skin of the back with povidone iodine. After local
anesthetic inﬁltration of the skin and subcutaneous tissue, the
upper edge of the spinous process of the ﬁfth thoracic vertebral
body (the commonest site used) was identiﬁed by counting
down from the seventh cervical body. With an epidural needle
(Tuohy 18 G; Braun, Melsungen, Germany) the injection point
was identiﬁed 3 cm lateral to the midline. The transverse
process of the sixth thoracic vertebra was contacted. The par-
avertebral space was punctured by advancing the Tuohy nee-
dle over the superior border of the transverse process. This
was typically at a depth of 4–6 cm from the skin. A loss-
of-resistance syringe was attached to the needle and, while
continuously testing for loss of resistance to air, the needle
was ‘‘walked off’’ the structure in an inferolateral (lateral
and caudal) direction and advanced approximately 1 cm (but
a maximum of 1.5 cm), ensuring that the bevel of the needle
pointed laterally, away from the medial structures. As the cos-
totransverse ligament was penetrated, a ‘‘pop’’ could usually
be felt, and there was loss of resistance to air. The ‘‘pop,’’ how-
ever, was not consistently reliable. After that a catheter was
advanced through the Touhy needle but with some difﬁculty
than the epidural one. Easy advancement of the catheter
may suggest that the catheter did not lie within the paraverte-
bral space because advancement in the paravertebral space
seemed to be associated with more resistance than anesthesiol-
ogists are used to in the epidural space. Although this observa-
tion has never been quantiﬁed or scientiﬁcally conﬁrmed, easy
advancement may imply that the catheter is intrapleural,
epidural, or intrathecal. The catheter was typically advanced
2–3 cm beyond the tip of the needle against some resistance,
which invariably causes the catheter to curl up in the paraver-
tebral space.After tunneling and securing the catheter, a test dose of
2 mL short-acting local anesthetic agent such as lidocaine
(2%) with 1/200,000 epinephrine was injected through the
catheter. Unintentional intrathecal injection should present
with subarachnoid block, whereas intravascular injection
should cause tachycardia.
Typically, 20 mL bupivacaine (0.5%) is administered in
5-mL incremental injections for intra- and postoperative
analgesia.
The dermatomal spread of the blocks was tested both by
sensation to cold stimuli (sensation to cold by dermatome
was tested with an ice-water ﬁlled plastic glove), as well as re-
sponse to a regular pinprick test, on dermatomes T1–T12 on
both sides of the spine. The quality of the block within each
dermatome was registered as complete block (++) = no sen-
sation to cold and pinprick, partial block (+) = block to cold
but still partial sensation of pinprick, or normal sensation (0).
The patient was then turned supine and given morphine
0.1 mg/kg IV. General anesthesia was induced as in the other
group. Ephedrine 10 mg was given IV as needed to keep
MAP within ±25% of baseline. All patients were tracheally
intubated and mechanically ventilated by using volume-con-
trolled positive-pressure ventilation.
2.5. Statistical analysis
Statistical analysis was performed with SPSS for Windows,
Release 11.0.1 (SPSS Inc., Chicago, IL). Normally distributed
data were analyzed by using unpaired Student’s t-tests or anal-
ysis of variance for repeated measurements, whereas for anal-
ysis of categorical and skewed data, Mann-Whitney U-tests, X2
tests, were used as appropriate. The categorical data are pre-
sented as, median (interquartile range), or number of patients.
P< 0.05 was considered statistically signiﬁcant
3. Results
Forty patients scheduled for thoracic surgery were divided into
two equal groups: group 1 who received general anesthesia fol-
lowed by IV opioids and group II who received thoracic para-
vertebral block before general anesthesia.
Patient’s characteristics were comparable in the two groups
(Table 1) as no signiﬁcant difference was found between the
two groups. Also, the heart rate (Fig. 1), mean arterial blood
pressure (Fig. 2).
There was statistically signiﬁcant difference between the
two groups as regards post operative pain at rest. Visual
analogue scale (VAS) at rest was lower in the paravertebral
Figure 1 Changes in heart rate in the two groups.
Figure 2 Changes in mean arterial blood pressure.
Table 3 Postoperative pain–pain on coughing during 24 h
after surgery, data expressed as median (interquartile range).
Time (h) Group I (n= 20) Group II (n= 20) P value
8 3.4(1.3/4.2) 1.6(0.9/3.1) 0.024
16 1.7(0.5/3.4) 0.6(0.3/1.3) 0.018
24 1.2(0.5/1.9) 0.6(0.2/1.5) 0.095
Table 4 Postoperative total morphine consumption at differ-
ent time points (mg).
Group I (n= 20) Group II (n= 20) P value
4 h 5 (3–8) 1 (0–2.5) 0.0007
8 h 7.5 (5–16) 2 (1–5) 0.0005
16 h 11 (9–20) 3 (1–8) 0.004
24 h 18.5 (11.5–21.5) 5 (1–10) 0.002
Total consumption 41.5 (7–16) 11 (0.75–8.25) 0.003
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(Table 2).
Comparison between the two groups as regards pain on
coughing shows signiﬁcant difference (P value < 0.05) at 8
and 16 h but not at 24 h which shows insigniﬁcant difference
(Table 3).
Post-operative median (25–75th percentiles) total use of
morphine (along 24 h) was 41.5 mg [7–16] in the control group
versus 11 (0.75–8.25) mg in the paravertebral block group
(PVB) (P value = 0.003). Morphine consumption was in-
creased signiﬁcantly in the control group at each time point
as reported in Table 4. Total bupivacaine dose used in the
PVB group administered through the catheter inserted in the
paravertebral space during the operative time as initial dose
and top-up doses was 300–420 mg.
As regards time to ﬁrst analgesic request this time was sig-
niﬁcantly longer in the group that used morphine as a soleTable 2 Postoperative pain–visual analogue scale (VAS) at
rest, data reported as median (interquartile range).
Time (h) Group I (n= 20) Group II (n= 20) P value
2 48(28–62) 30(19–49) 0.019
4 35(13–42) 17(09–31) 0.025
6 17(7–37) 9(5–14) 0.016
8 14(5–34) 7(3–13) 0.019
12 15(8–33) 6(0–15) 0.016
16 13(5–19) 7(2–15) 0.096
20 8(1–24) 7(1–13) 0.730
24 7(1–23) 6(1–11) 0.830
P value < 0.05 = signiﬁcant. VAS 0 mm= no pain, 100 mm=
intolerable pain.analgesic postoperatively than the other group that used para-
vertebral block as a postoperative analgesic. VAS at ﬁrst anal-
gesic request was not statistically different between the two
groups as shown in Fig. 3.
There was no signiﬁcant difference between the two groups
as regards to peak expiratory ﬂow rate (PEFR) preoperatively,
after 12 h or 24 h. As shown in Table 5.
There was a signiﬁcant reduction in the incidence of side
effects in patients who received thoracic paravertebral block
as a postoperative analgesia (group II) in comparison to the
patients who received intravenous morphine as a sole analgesic
agent (group I). Eleven patients in group I reported side effects
while only three patients in group II had side effects. Some
patients reported both vomiting and pruritus while others
developed only one side effect. As shown in Table 6. No
patient in the PVB complained of symptoms of LA toxicity
(convulsions and cardiac dysrhythmias). (Most signs of LA
toxicity could be masked by general anesthesia.)Figure 3 Time to ﬁrst analgesic request (minutes).
Table 5 Pulmonary functions–comparison between the two
groups.
PEFR (L/min) Group I (n= 20) Group II (n= 20)
Pre-operative 370 (250–440) 340 (240–430)
After 12 h 230 (180–320) 220 (130–310)
After 24 h 240 (170–330) 200 (180–300)
Data are presented as median (interquartile range) as appropriate.
Table 6 Comparison between the two groups as regards side
effects.
Side eﬀects Group I (n= 20) Group II (n= 20) P value
No side eﬀects 9 (45%) 17 (85%) 0.01
Nausea, vomiting 11 3
Pruritis 7 0
P value < 0.05 = signiﬁcant.
Post-thoracotomy pain relief: Thoracic paravertebral block compared with systemic opioids 594. Discussion
This prospective, randomized trial demonstrates that thoracic
paravertebral block with a catheter using bupivacaine as a
local anesthetic provides better postoperative analgesia than
intravenous morphine as a sole analgesic agent in patients
undergoing lung surgery via a posterolateral midthoracic
thoracotomy incision.
The paravertebral space is a wedge – shaped space that lies
to the side of the vertebral column and contains the spinal
(intercostal) nerve, the dorsal ramus, the rami communicantes
and the sympathetic chain. Placement of local anesthetic with-
in the paravertebral space produces unilateral somatic and
sympathetic block, which is advantageous for unilateral surgi-
cal procedures of the chest and abdomen [3].
The use of this technique for control of post-thoracotomy
pain was done to try a simple and effective technique for
analgesia and to avoid the side effects of systemic opioids
and even epidural blocks. As the thoracotomy incision is one
sided no need for extended block. This technique has minimal
hemodynamic effects, preserves respiratory functions and
devoid of side effects of systemic morphine.
In our study thoracic PVB produced no signiﬁcant differ-
ences in hemodynamics (heart rate, mean arterial blood pres-
sure, oxygen saturation) as compared to control group either
intraoperatively or postoperatively. These results were in agree
with the results of Dabbagh and Elyasi who used PVB in
breast surgery in the form of a single preoperative injection
of lidocaine 2% in the paravertebral space and compared it
with general anesthesia and noted that PVB did not affect
hemodynamics as no patient out of 30 patients suffered from
hypotension or bradycardia [4].
The dose of bupivacaine (20 mL 0.5%) which was used in
our study as a pre-emptive dose was similar to several studies
such as Andre´ and colleagues who used the same dose in a
catheter for breast surgery [5]. Also Richardson and colleagues
used the same dose in a large study [6].
As regards the effect of paravertebral block on postopera-
tive pain either at rest or on coughing, this was the main goal
of this study, we observed that paravertebral block produced
signiﬁcant decrease in VAS postoperatively in the ﬁrst 16 h
as compared to intravenous morphine. Patients in PVB group
reported less pain at rest and on coughing than patients in the
morphine group.
These results were similar to the results of Bilgin et al.
(2003) who compared the effects of continuous paravertebral
block (with a catheter) using bupivacaine to intravenous
metamizol as a systemic analgesic. They found that paraverte-
bral block decreased pain severity signiﬁcantly than the sys-
temic analgesic up to 72 h postoperatively [7].
Also Kairaluoma et al. (2006) found nearly the same results
as those in our study when they compared pre-incisionalparavertebral block (single injection) with bupivacaine to IV
oxycodone for relieving postoperative pain after breast sur-
gery. PVB in this study reduced chronic pain symptoms up
to 12 months postoperatively [8].
Hill et al. showed also signiﬁcant difference between PVB
group and IV morphine group after thoracoscopic procedures
as regards cumulative morphine consumed but only in the ﬁrst
6 h postoperatively. Median cumulative morphine use in the
PVB group at 6 h after paravertebral injection was 0.11 mg/
kg compared with 0.17 mg/kg in the placebo group
(P= 0.029). Also this could be explained by the absence of
a catheter for supplemental doses of bupivacaine [9].
As regards peri-operative respiratory functions, we used
peak expiratory ﬂow rate (PEFR) as a measurement of respi-
ratory functions like Richardson and his colleagues (1999) in
the largest controlled trial over 100 adult patients underwent
thoracotomy incisions that used PEFR as a measurement of
peri-operative respiratory functions. They concluded that
pulmonary function as assessed by PEFR was signiﬁcantly bet-
ter preserved in the PVB group as compared to the thoracic
epidural one [6].
Barron et al. used two regimens of bupivacaine dose, low
dose regimen ranged from 310–450 mg and high dose regimen
ranged from 890–990 mg in the ﬁrst 24 h. They used continu-
ous paravertebral blockade for post-thoracotomy analgesia
and concluded that higher dose paravertebral bupivacaine
was strongly predictive of lower VAS scores at rest, when com-
pared with lower dose regimes at 8 h after operation, 24 h and
48 h Although there was a trend to improved analgesia on
coughing at all time points, the difference did not reach statis-
tical signiﬁcance [11].
Total morphine consumed by patients in the PVB group in-
cluded in our study was signiﬁcantly less than that consumed
by patients in the control group (24 h postoperatively, group
I = 18.5 (11.5–21.5) mg vs. Group II = 5 mg [1–10]). This
observation was the same as Kairaluoma et al. who observed
that patients who received pre-emptive single injection PVB
needed signiﬁcantly less IV oxycodone than patients who did
not receive PVB but only in the period of post-anesthesia care
unit (PACU), however there was no signiﬁcant difference be-
tween the two groups as regards oxycodone consumption after
8 h up to 24 h. This could be explained by the single injection
of bupivacaine not continuous injection via a catheter [12].
Hill et al. showed also signiﬁcant difference between PVB
group and IV morphine group after thoracoscopic procedures
as regards cumulative morphine consumed but only in the ﬁrst
6 h postoperatively. Median cumulative morphine use in the
PVB group at 6 h after paravertebral injection was 0.11 mg/kg
compared with 0.17 mg/kg in the placebo group (P= 0.029).
Also this could be explained by the absence of a catheter for
supplemental doses of bupivacaine [9].
As regards peri-operative respiratory functions, we used
peak expiratory ﬂow rate (PEFR) as a measurement of respi-
ratory functions like Richardson and his colleagues (1999) in
the largest controlled trial over 100 adult patients underwent
thoracotomy incisions that used PEFR as a measurement of
peri-operative respiratory functions. They concluded that
pulmonary function as assessed by PEFR was signiﬁcantly bet-
ter preserved in the PVB group as compared to the thoracic
epidural one [6].
In our study there was no signiﬁcant difference between PVB
patients and control group patients as regards peri-operative
60 S.M. Asida et al.respiratory functions assessed by PEFR either preoperatively,
after 12 h or 24 h.
Our results were similar to the results of Vogt et al. who
used a single-injection thoracic paravertebral block for postop-
erative pain treatment after thoracoscopic surgery compared
with a control group in whom a back puncture was done with-
out injecting morphine to the patient. They used PEFR as a
measurement of peri-operative pulmonary functions and ob-
served that after 24 and 48 h. of surgery the groups did not dif-
fer with regard to peak expiratory ﬂow rate [13].
Hill et al. showed that there was no signiﬁcant difference
between single-dose multi-level paravertebral block and sys-
temic analgesia using PCA morphine as regards peri-operative
pulmonary functions. They used forced vital capacity (FVC)
and forced expiratory volume in 1st second (FEV1) as mea-
surements of pulmonary functions [9].
The results of Bilgin et al. were against our results as they
observed that there was a signiﬁcant reduction in FEV1 and
FVC in the systemic analgesia group (group II) (using metam-
izol) when compared with PVB group (group I) 24 h and 48 h
postoperatively. A decrease in FVC and FEV1 values was
found in both groups when compared to the preoperative val-
ues. On the ﬁrst day when the mean FVC and FEV1 values
were compared with the preoperative values, in group I FVC
was 54% and FEV1 was 55% and in group II, FVC was
42% and FEV1 was 38% of the preoperative values [7].
We observed that in our study there was a signiﬁcant reduc-
tion in the incidence of side effects in patients who received
thoracic paravertebral block as a postoperative analgesia
(group II) in comparison to the patients who received intrave-
nous morphine as a sole analgesic agent (group I). Leaven pa-
tients in group I reported side effects while only three patients
in group II had side effects. These side effects were nausea,
vomiting and pruritis.
Our results were similar to the results of Naja et al. as
regards postoperative nausea and vomiting (PONV). They
studied nerve-stimulator guided paravertebral blockade versus
general anesthesia for breast surgery in a prospective random-
ized trial. They observed that the incidence of PONV was
signiﬁcantly lower in the PVB group [14].
El-Nasr et al. who studied the effects of paravertebral
blockade versus general analgesia for breast surgery, con-
cluded that PVB is associated with signiﬁcantly less incidence
of PONV [15].
In our study, no patients suffered from complications due
to LA toxicity manifested by convulsions or cardiac dysrhyth-
mias. Lower doses of bupivacaine which were given in
incremental doses after test doses (with epinephrine) may con-
tribute to the absence of toxicity complications.
In a systemic review and metaregression by Kotze´ et al. in
2009 the investigators studied the efﬁcacy and safety of different
techniques of paravertebral block for analgesia after thoracot-
omy. They studied 25 controlled trials and concluded that the
occurrence of complications of the PVB or of surgery was not
as well reported as pain scores and pulmonary function. Possi-
ble LA toxicity was the only complication reported in themajor-
ity of studies. Only 15 of the 19 studies using bupivacaine
reported speciﬁcally whether this complication occurred or
not. Neurological effects which may have been due to LA toxic-
ity occurred in four of 225 patients in the higher dose bupiva-
caine trials, compared with two of 110 patients in the lower
dose trials (P= 1.0). Cardiac arrhythmias occurred in two of173 patients who received higher dose bupivacaine, and none
of the 69 patients who received lower dose bupivacaine
(P= 1.0). No lasting patient harmwas reported due to possible
LA toxicity [16].
We conclude that continuous thoracic PVB with bupiva-
caine provides effective analgesia after thoracic surgery sup-
ported by lower values of VAS pain scores at rest and when
coughing as compared to systemic analgesia with signiﬁcant
less incidence of complications and side effects such as pul-
monary complications, PONV and pruritus.References
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